| Midnight salivary cortisol (nmol/L) | |||
---|---|---|---|---|
 | n (%) | Median (q1, q3;range) | P1 | |
All participants |  | 196 | 5.0 (3.1, 7.5; 1.9–47.0) |  |
Gender | Â | |||
Men |  | 106 (54) | 4.6 (3.1, 6.8; 1.9–47.0) | 0.062 |
Women |  | 90 (46) | 5.6 (3.2, 8.0; 1.9–23.0 ) | |
Psychiatric variables | Â | |||
Depression2 | Yes | 20 (10) | 7.7 (5.0, 13.0; 1.9–31.0) | 0.005 |
No | 176 (90) | 4.8 (3.0, 7.1; 1.9–47.0) | ||
Depression2 and antidepressants (Sub analysis) | Â | |||
Depression2, using antidepressants |  | 5 (2) | 8.7 (3.3; 18.0; 3.0–26.0) | 0.76 |
Depression2, not using antidepressants |  | 15 (8) | 6.7 (5.1; 13.0; 1.9–31.0) | |
No depression2, using antidepressants |  | 8 (4) | 4.4 (3.1; 8.6; 2.9–14.0) | 0.90 |
No depression2, not using antidepressants |  | 168 (86) | 4.8 (3.0; 7.1; 1.9–47.0) | |
Clinical psychiatric diagnoses | Yes | 27 (14) | 5.3 (3.7, 9.4; 1.9–26.0) | 0.28 |
No | 169 (86) | 5.0 (3.0, 7.4; 1.9–47.0) | ||
Life style factors | Â | |||
Smoking | Yes | 16 (9) | 9.0 (6.6, 11.8; 2.3–47.0) | <0.001 |
No | 170 (91) | 4.8 (3.0, 7.0; 1.9–31.0) | ||
Physical inactivity | Yes | 19 (10) | 6.3 (4.3, 13.0; 1.9–31.0) | 0.050 |
No | 165 (90) | 4.9 (3.0, 7.2; 1.9–47.0) | ||
Metabolic variables and hypoglycemia episodes | Â | |||
HbA1c >70 mmol/mol (>8.6%) | Yes | 50 (26) | 5.3 (3.7, 7.6; 1.9–31.0) | 0.26 |
No | 146 (74) | 4.8 (3.0, 7.5; 1.9–47.0) | ||
Abdominal obesity, men3 | Yes | 8 (8) | 3.8 (2.5, 5.4; 1.9–31.0) | 0.37 |
No | 96 (92) | 4.8 (3.1, 7.2; 1.9–47.0) | ||
Abdominal obesity, women4 | Yes | 21 (24) | 7.1 (5.1, 8.8; 2.9–20) | 0.030 |
No | 65 (76) | 5.0 (2.9, 7.8; 1.9–23.0) | ||
Severe hypoglycemia episodes5 | Yes | 9 (5) | 5.4 (3.4, 6.5; 2.4–11.0) | 0.96 |
No | 186 (95) | 5.0 (3.1, 7.6; 1.9–47.0) | ||
Medication | Â | |||
Antidepressants | Yes | 13 | 4.4 (3.3, 9.7; 2.9–26.0) | 0.53 |
No | 183 | 5.0 (3.1, 7.4; 1.9–47.0) | ||
Inhaled steroids | Yes | 15 (8) | 5.4 (3.0, 7.6; 2.3–11.0) | 0.88 |
No | 181 (92) | 5.0 (3.1, 7.5; 1.9–47.0) |